Please assess the completion status of the following clinical trial:

Trial Title: Early Primary Prophylaxis of Esophageal Varices

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~- Patients of cirrhosis with portal hypertension aged 18 to 75 years who have small esophageal varices with or without red color signs and have not bled previously.~Exclusion Criteria:~* Any contra-indication to beta-blockers~* Any EVL or sclerotherapy within last 3 months~* Child Turcotte Pugh (CTP) score \> 12, refractory ascites, hepatorenal syndrome~* Any past history of surgery for portal hypertension~* Significant cardio or pulmonary co-morbidity~* Any malignancy that affects survival.~* Active alcohol abuse or last intake ≤ 4 weeks to avoid possibility of ongoing alcohol hepatitis.~* Past history of surgery for portal hypertension~* Uncontrolled diabetes~* Peripheral vascular disease~* Refusal to participate in the study

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- Carvedilol (Type: EXPERIMENTAL): Tablet Carvedilol 12.5 mg BD or maximum tolerated dose
- Placebo (Type: PLACEBO_COMPARATOR): Placebo tablets 2 to 4 BD

Based on this trial design, predict the completion outcome and termination type (if applicable).